U.S. Physical Therapy, Inc. (USPH)

U.S. Physical Therapy Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	28.88	28.24	32.16	40.83	35.19	40.04
Depreciation & Amortization	16	15.7	14.74	11.59	10.53	10.1
Share-Based Compensation	7.43	7.24	7.26	7.87	7.92	6.99
Other Operating Activities	22.74	30.81	4.37	16.12	46.35	5.33
Operating Cash Flow	75.05	81.98	58.54	76.41	100	62.45
Operating Cash Flow Growth	28.87%	40.04%	-23.39%	-23.59%	60.13%	-14.46%
Capital Expenditures	-9.07	-9.29	-8.25	-8.2	-6.8	-10.19
Acquisitions	-44.13	-36.04	-73.02	-115.94	-44.4	-27.8
Other Investing Activities	0.41	0.32	-	-	-	-
Investing Cash Flow	-52.8	-45.02	-81.27	-124.14	-51.2	-37.99
Dividends Paid	-24.13	-24.13	-21.32	-18.77	-4.11	-14.56
Share Issuance / Repurchase	163.65	163.65	0	0	0	0
Debt Issued / Paid	-46.12	-39.15	62.42	79.05	-16.98	6.57
Other Financing Activities	-15.96	-16.1	-15.34	-16.9	-18.33	-16.29
Financing Cash Flow	77.44	84.27	25.76	43.38	-39.42	-24.28
Net Cash Flow	99.69	121.23	3.03	-4.35	9.37	0.18
Free Cash Flow	65.98	72.68	50.29	68.21	93.2	52.26
Free Cash Flow Growth	30.75%	44.53%	-26.27%	-26.81%	78.33%	-20.59%
Free Cash Flow Margin	10.78%	12.02%	9.09%	13.78%	22.03%	10.84%
Free Cash Flow Per Share	4.39	5.12	3.87	5.29	7.26	4.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).